NFKB1 and Parkinson disease: NF-κB has proven to be strongly involved in the propagation of neuroinflammatory processes in PD, feeding into one of the most pathologic components in this condition; thus, targeting this NF-κB pathway by EGCG, quercetin, and kaempferol makes these flavonoids even more promising therapeutics for the treatment of PD.